CoChat

Hippocampal Proliferation Is Increased in Presymptomatic Parkinson’s Disease and due to Microglia

Open access
Doorn, Karlijn J., Drukarch, Benjamin, van Dam, Anne-Marie, Lucassen, Paul J. · 2014 · Neural Plasticity

The DOI matches its Crossref record; 91 of the 91 references it cites were found in a registry or an index.

Abstract

Besides dopamine-deficiency related motor symptoms, nonmotor symptoms, including cognitive changes occur in Parkinson's disease (PD) patients, that may relate to accumulation of α-synuclein in the hippocampus (HC). This brain region also contains stem cells that can proliferate. This is a well-regulated process that can, for example, be altered by neurodegenerative conditions. In contrast to proliferation in the substantia nigra and subventricular zone, little is known about the HC in PD. In addition, glial cells contribute to neurodegenerative processes and may proliferate in response to PD pathology. In the present study, we questioned whether microglial cells proliferate in the HC of established PD patients versus control subjects or incidental Lewy body disease (iLBD) cases as a prodromal state of PD. To this end, proliferation was assessed using the immunocytochemical marker minichromosome maintenance protein 2 (MCM2). Colocalization with Iba1 was performed to determine microglial proliferation. MCM2-positive cells were present in the HC of controls and were significantly increased in the presymptomatic iLBD cases, but not in established PD patients. Microglia represented the majority of the proliferating cells in the HC. This suggests an early microglial response to developing PD pathology in the HC and further indicates that neuroinflammatory processes play an important role in the development of PD pathology.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1155/2014/959154

Cites

91 of 91 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 α-Synuclein pathology present in the hippocampus of PD cases. (a-b) α-Synuclein immunoreactivity (IR) in CA of control and iLBD subjects is absent compared to (c) α-synuclein IR (LBs: arrow, LNs: arrowhead) in the CA region of PD patients; bar (a–c) = 100 μm; higher magnification (c′) bar = 20 μm.
Figure 1 α-Synuclein pathology present in the hippocampus of PD cases. (a-b) α-Synuclein immunoreactivity (IR) in CA of control and iLBD subjects is absent compared to (c) α-synuclein IR (LBs: arrow, LNs: arrowhead) in the CA region of PD patients; bar (a–c) = 100 μm; higher magnification (c′) bar = 20 μm.CC BY · PubMed Central
Figure 2 MCM2-positive cells in the hippocampal CA3 region of an iLBD case. High magnification of MCM2 IR reveals clear examples of doublets (arrows). The MCM2-positive cell indicated with the arrowhead is closely opposed to a large pyramidal neuron; bar = 25 μm.
Figure 2 MCM2-positive cells in the hippocampal CA3 region of an iLBD case. High magnification of MCM2 IR reveals clear examples of doublets (arrows). The MCM2-positive cell indicated with the arrowhead is closely opposed to a large pyramidal neuron; bar = 25 μm.CC BY · PubMed Central
Figure 3 MCM2-positive cell numbers in control subjects, iLBD cases, and PD patients. Semiquantitative analysis revealed that in (a) control subjects, a significant main effect was present (P = 0.034; related nonparametric Friedman's analysis) with higher numbers of MCM2-positive cells in the DG compared to the hippocampal subregions (DG versus CA3 and CA4 # P = 0.043; DG versus CA1 P = 0.08 n.s.; DG versus CA2 P = 0.225 n.s.; nonparametric paired Wilcoxon post hoc test). (b, c) In the iLBD and PD cases, no differences were present between any of the subregions. Significance reached at alpha of P ≤ 0.02, FWE-corrected. Data represent mean ± SEM.
Figure 3 MCM2-positive cell numbers in control subjects, iLBD cases, and PD patients. Semiquantitative analysis revealed that in (a) control subjects, a significant main effect was present (P = 0.034; related nonparametric Friedman's analysis) with higher numbers of MCM2-positive cells in the DG compared to the hippocampal subregions (DG versus CA3 and CA4 # P = 0.043; DG versus CA1 P = 0.08 n.s.; DG versus CA2 P = 0.225 n.s.; nonparametric paired Wilcoxon post hoc test). (b, c) In the iLBD and PD cases, no differences were present between any of the subregions. Significance reached at alpha of P ≤ 0.02, FWE-corrected. Data represent mean ± SEM.CC BY · PubMed Central
Figure 4 MCM2-positive cell numbers in the total HC and different hippocampal subregions. (a) The total number of MCM2-positive cells in the HC was significantly higher in iLBD cases compared to control subjects (*P = 0.004; nonparametric Mann-Whitney U test). (b–f) Comparing MCM2 IR per HC subregion between the 3 different groups revealed a significant increase in number of proliferating cells in hippocampal areas (d) CA3 and (e) CA4 (resp., *P = 0.001, *P = 0.003; nonparametric Mann-Whitney U test) of iLBD cases versus control subjects. Significance reached at alpha of P ≤ 0.016, Bonferroni-corrected. Data represent mean ± SEM.
Figure 4 MCM2-positive cell numbers in the total HC and different hippocampal subregions. (a) The total number of MCM2-positive cells in the HC was significantly higher in iLBD cases compared to control subjects (*P = 0.004; nonparametric Mann-Whitney U test). (b–f) Comparing MCM2 IR per HC subregion between the 3 different groups revealed a significant increase in number of proliferating cells in hippocampal areas (d) CA3 and (e) CA4 (resp., *P = 0.001, *P = 0.003; nonparametric Mann-Whitney U test) of iLBD cases versus control subjects. Significance reached at alpha of P ≤ 0.016, Bonferroni-corrected. Data represent mean ± SEM.CC BY · PubMed Central
Figure 5 Colocalization of the majority of MCM2-positive cells with Iba1 in the hippocampal CA3 region of control subjects, iLBD cases and PD patients. (a–f) Representative confocal laser scanning microscopical images of double-immunofluorescent stained sections revealed that the majority of the MCM2-positive cells show colocalization with the microglial marker Iba1 (arrows in (c), (f), (i) and (j), and (k) and (l)). Iba1-positive microglia are depicted in green (a, d, and g) and MCM2 in red (b, e, and h). (j–l) Higher magnification of colocalization (l) between Iba1-positive microglia ((j), green) and MCM2 ((k), red); bar (a–i) = 40 μm; (j–l) = 10 μm.
Figure 5 Colocalization of the majority of MCM2-positive cells with Iba1 in the hippocampal CA3 region of control subjects, iLBD cases and PD patients. (a–f) Representative confocal laser scanning microscopical images of double-immunofluorescent stained sections revealed that the majority of the MCM2-positive cells show colocalization with the microglial marker Iba1 (arrows in (c), (f), (i) and (j), and (k) and (l)). Iba1-positive microglia are depicted in green (a, d, and g) and MCM2 in red (b, e, and h). (j–l) Higher magnification of colocalization (l) between Iba1-positive microglia ((j), green) and MCM2 ((k), red); bar (a–i) = 40 μm; (j–l) = 10 μm.CC BY · PubMed Central
Figure 6 Colocalization of the majority of MCM2-positive cells with Iba1 in the hippocampal DG region of control subjects, iLBD cases, and PD patients. (a–f) Representative confocal laser scanning microscopical images of double-immunofluorescent stained sections revealed that the majority of the MCM2-positive cells show colocalization with the microglial marker Iba1 (arrows in (c), (f), and (i)). (b, d) Control subject shows one MCM2-positive cell with no colocalization with Iba1 (arrowhead). Iba1-positive microglia are depicted in green (a, d, and g) and MCM2 in red (b, e, and h); bar (a–i) = 40 μm.
Figure 6 Colocalization of the majority of MCM2-positive cells with Iba1 in the hippocampal DG region of control subjects, iLBD cases, and PD patients. (a–f) Representative confocal laser scanning microscopical images of double-immunofluorescent stained sections revealed that the majority of the MCM2-positive cells show colocalization with the microglial marker Iba1 (arrows in (c), (f), and (i)). (b, d) Control subject shows one MCM2-positive cell with no colocalization with Iba1 (arrowhead). Iba1-positive microglia are depicted in green (a, d, and g) and MCM2 in red (b, e, and h); bar (a–i) = 40 μm.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 91 references

Research works printed but not linked: 5

  1. 2002, Journal of Neurology, 249, 1
  2. 2012, Parkinsonism & Related Disorders, 18, S28
  3. 2009, Journal of Neural Transmission. Supplementum, 279
  4. 2014, PloS ONE, 9
  5. 2012, Parkinsonism and Related Disorders, 18, S210

Cited by

See all 25

Metadata

Authors
Doorn, K. J., Drukarch, B., van Dam, A.-M., & Lucassen, P. J.
Affiliations
  • Amsterdam Neuroscience (NL)
  • Neuroscience Campus Amsterdam (NCA), Free University (VU) Medical Center, Van der Boechorststraat 7, 1081 BT Amsterdam, The Netherlands
  • University of Amsterdam (NL)
Corresponding author
Lucassen, Paul J.
Venue
Neural Plasticity
Published
2014
Volume
2014
Pages
1-13
ISSN
  • 1687-5443 (ISSN-L)
  • 2090-5904
OpenAlex
W1966166173
Cited by
24
References
91
Citations by year
2026: 1 · 2025: 1 · 2021: 3 · 2020: 3 · 2019: 3 · 2018: 2 · 2017: 3 · 2016: 3 · 2015: 3 · 2014: 2
FWCI
1.91
Type
journal article
Language
en
Open access
Locations
  • Neural Plasticity (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Pure Amsterdam UMC (publishedVersion)
  • Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
  • UvA-DARE (University of Amsterdam) (acceptedVersion, other-oa)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
  • Data Archiving and Networked Services (DANS) (submittedVersion)
Funders
  • Internationale Parkinson Fonds (IPF)
  • Alzheimer Nederland and the Internationale Stichting Alzheimer Onderzoek (ISAO)
Topics
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
  • Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
  • Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
Keywords
Parkinson's disease, incidental Lewy body disease, hippocampus, microglial proliferation, neuroinflammation, MCM2, Iba1, alpha-synuclein, non-motor symptoms, prodromal Parkinson's disease
MeSH terms
Aged, Aged, 80 and over, Female, Hippocampus, Humans, Male, Parkinson Disease, Microglia, Cell Proliferation, alpha-Synuclein, Prodromal Symptoms

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Hippocampal Proliferation Is Increased in Presymptomatic Parkinson’s Disease and due to Microglia. https://app.cochat.ai/papers/10.1155/2014/959154
The paper
Doorn, K. J., Drukarch, B., van Dam, A.-M., & Lucassen, P. J. (2014). Hippocampal Proliferation Is Increased in Presymptomatic Parkinson’s Disease and due to Microglia. Neural Plasticity. https://doi.org/10.1155/2014/959154

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.